3SBio, Inc.

3SBio, Inc.

3SBio, Inc.

Overview
Date Founded

2006

Headquarters

Shenyang Economy & Tech Development,No. 3 A1, Road 10,Shenyang, Liaoning 110027

Type of Company

Public

Employees (Worldwide)

5,404

Industries

Biotechnology

Company Description

3SBio, Inc. operates as in investment holding company which engages in the development, production, marketing, and sale of biopharmaceutical products. It is used in the field of medicine particularly in nephrology, oncology, supportive cancer care, inflammation, and infectious diseases. The company was founded by Jing Lou and Dan Lou in 1993 and is headquartered in Shenyang, China.

Contact Data
Trying to get in touch with decision makers at 3SBio, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Co-Founder

Senior Vice President, General Manager, Executive Director

Chief Operating Officer

Chief Scientific Officer & President-Research

Chief Financial Officer

General Manager of Sunshine Guojian

Director, Corporate Development

Director-Finance Department

Director, Finance

Joint Company Secretary

Paths to 3SBio, Inc.
Potential Connections via
Relationship Science
You
3SBio, Inc.
Owners & Shareholders
Details Hidden

CFE is a growth-oriented asset manager that invests in a limited number of quality growth companies with the aim of offering an above-average long-term return with minimum risk. The firm’s investment process includes: (1) broad screen of market; (2) analysis of candidates; (3) entry into the investment universe; (4) valuation; (5) portfolio construction. Their stocks focus on bottom-up stock picking. CFE’s investment team monitors portfolio companies’ business models through frequent field research.

Details Hidden

Part of ASPOMA Holding AG, ASPOMA Asset Management GmbH is a company headquartered in Linz, Austria, that provides investment advice. The firm was founded in 2010 by Harald Staudinger and Ming Han Jiang. Harald Staudinger has been the CEO since the company founding.

Details Hidden

EI-HK provides investment solutions across a broad range of asset classes including equities, fixed-income, multi-assets solutions, quantitative investment solutions and alternatives. They are a signatory to the UN-supported Principles of Responsible Investment, incorporating environmental, social and governance (ESG) considerations in the firm’s investment process.

Recent Transactions
Details Hidden

purchases Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. from 3SBio, Inc.

Details Hidden

3SBio, Inc., Shanghai Hongshang Investment Co., Ltd. purchase Shanghai Xingsheng Pharmaceutical Co., Ltd. from Shanghai Lansheng Corp.

Details Hidden

3SBio, Inc. purchases Shanghai CP Guojian Pharmaceutical Co., Ltd.

Transaction Advisors
Global Coordinator

Advised on3SBio, Inc. issued HKD Ordinary Shares

Underwriter

Advised on3SBio, Inc. issued HKD Ordinary Shares

Sponsor

Advised on3SBio, Inc. issued HKD Ordinary Shares

Counsel

Advised on3SBio, Inc., Shenyang Sunshine Pharmaceutical Co., Ltd. purchase Zhejiang Wansheng Pharmaceutical Co., Ltd. from CITIC Mezzanine (Shanghai) Investment Center LP

Legal Advisor

Advised on3SBio, Inc., Shenyang Sunshine Pharmaceutical Co., Ltd. purchase Zhejiang Wansheng Pharmaceutical Co., Ltd. from CITIC Mezzanine (Shanghai) Investment Center LP

Legal Advisor

Advised on purchases 3SBio, Inc.

Advisors & Consultants
Legal Advisor

Head of Listing at Hong Kong Exchanges and Clearing Ltd.

Legal Advisor

Co-Head, Hong Kong at Davis Polk & Wardwell LLP

Managing Partner at MinterEllison

Clients

Selecta Biosciences, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. It produces the Synthetic Vaccine Particles (SVP) platform for immune tolerance and immune stimulation. The firm's proprietary pipeline includes SVP-enabled enzyme, oncology and gene therapies. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian in 2007 and is headquartered in Watertown, MA.

Eris Lifesciences Ltd. engages in the provision of pharmaceutical products. Its products include Atorsave, D500cal, Decal, Enoxsave, Eritel, Eritel Trio, Glimsave, Ramisave, Remylin, Superclop and Triglimisave. The firm markets and distributes pharmaceutical drugs, such as tablets, syrups and injections. The company was founded by Amit Indubhushan Bakshi on January 25, 2007 and is headquartered in Ahmedabad, India.

Key Stats and Financials As of 2019
Market Capitalization
$2.32B
Total Enterprise Value
$3.42B
Earnings Per Share
$0.06
EBITDAMargin
29.4%
Enterprise Value / Sales
4.44x
Enterprise Value EBITDAOperating
15.11x
TEVNet Income
24.27x
Debt TEV
0.12x
Three Year Compounded Annual Growth Rate Of Revenue
23.88%
Five Year Compounded Annual Growth Rate Of Revenue
36.29%
Revenue
$770M
Net Profit
$141M
EBITDA
$226M
Total Debt
$412M
Total Equity
$1.48B
Investments
Details Hidden

Numab Therapeutics AG is a biopharmaceutical company, which engages in the development of cancer immunotherapy. Its focuses on creating multi-specific antibodies that enable the pursuit of novel therapeutic strategies. The company was founded by Oliver Middendorp, David Urech, and Peter Lichtlen in 2011 and is headquartered in Wadenswil, Switzerland.

Details Hidden

Verseau Therapeutics, Inc. provides immuno-therapy services. The company was founded by Daniel Anderson, Robert Langer, Igor Feldman, and Tatiana Novobrantseva in 2017 and is headquartered in Bedford, MA.

Details Hidden

Refuge Biotechnologies, Inc. develops therapeutic cells. It is leveraging gene engineering technologies known as CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa) to develop therapeutic cells that are programmed to make decisions inside the patient’s body. The firms programs include RB-1916, RB-H21 and RB-M1. The company was founded by Stanley Qi, David R. Parkinson and Bing C. Wang and is headquartered in Menlo Park, CA.

Investors
Details Hidden

CITICPE is an active manager which invests in middle-market capital requirements. The firm provides equity financing in the technology and internet sector, industry and energy, financial and business services, consumption and leisure, medical and health industry and real estate transactions. It invests in corporations located in China.

Suppliers
Aurinia Pharmaceuticals, Inc. Hospitals & Patient Services | Victoria, Canada

Aurinia Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of a therapeutic drug to treat autoimmune diseases. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Victoria, Canada.

AstraZeneca Plc Other Manufacturing | Cambridge, United Kingdom

AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Eli Lilly & Company Hospitals & Patient Services

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. Its products include Forteo, Adrica, BAQSIMI, Basaglar and Glucagn. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by 3SBio, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of 3SBio, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and 3SBio, Inc..